Recurrent Intrathoracic Liposarcoma: A Case Report and a Comprehensive Literature Review of a Rare Clinical Entity
- PMID: 39463647
- PMCID: PMC11512469
- DOI: 10.7759/cureus.70241
Recurrent Intrathoracic Liposarcoma: A Case Report and a Comprehensive Literature Review of a Rare Clinical Entity
Abstract
Liposarcomas (LPSs) are rare malignant tumors of adipocytic origin, primarily occurring in the extremities and retroperitoneum, with thoracic involvement being exceptionally rare. This case report details the surgical management and outcomes of a recurrent intrathoracic LPS in a 65-year-old male with a history of previous mediastinal tumor resection. CT imaging revealed a recurrent tumor extending into the left pleura. The patient underwent a posterolateral thoracotomy for complete tumor excision and limited replacement of the descending aorta. Postoperative recovery was smooth, and histology confirmed dedifferentiated LPS (G2) with areas of highly differentiated LPS. LPSs encompass a heterogeneous group of tumors with various subtypes, including atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLPS), dedifferentiated liposarcoma (DDLPS), myxoid liposarcoma (MLPS), and pleomorphic liposarcoma (PLPS). Treatment primarily involves complete surgical resection, while the roles of radiotherapy and chemotherapy remain debated. Immunotherapy shows potential benefits, particularly for DDLPS patients expressing PD-L1. Prognosis varies significantly by subtype, with DDLPS and PLPS associated with poorer outcomes compared to MLPS and ALT/WDLPS. Long-term follow-up is crucial for managing LPSs due to their high recurrence rate. This case highlights the effectiveness of surgical intervention in recurrent intrathoracic LPSs and underlines the need for continued research into adjuvant therapies to improve patient outcomes.
Keywords: adjuvant therapy; dedifferentiated liposarcoma (ddlps); long-term follow-up; pleural liposarcoma; recurrent intrathoracic liposarcoma; surgical resection.
Copyright © 2024, Leivaditis et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures






References
-
- Well-differentiated and dedifferentiated liposarcomas. Coindre JM, Pédeutour F, Aurias A. Virchows Arch. 2010;456:167–179. - PubMed
-
- Thoracic liposarcoma in an end stage renal disease patient. Ishtiaq R, Naeem A, Ratnani I. https://pubmed.ncbi.nlm.nih.gov/31094134/ J Ayub Med Coll Abbottabad. 2019;31:286–289. - PubMed
-
- Liposarcoma of the pleural cavity. Kawai T, Nakashima H, Washimi K, et al. Hum Pathol. 2023;136:105–113. - PubMed
-
- Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CD. Am J Surg Pathol. 2004;28:1257–1267. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials